Definitive Contract HHSN268201700001C

Award Date 11/15/16
Potential Completion Date 11/14/20
Potential Value $1.6M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27710, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Duke University for the "LONG TERM OXYGEN TREATMENT TRIAL". The contract has a total ceiling value of $2,316,894.97 and was awarded on October 31, 2006, with a final completion date of June 30, 2016. Duke University, as the prime contractor, will provide clinical research services related to long-term oxygen treatment. The contract...
The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $54,900 firm fixed price purchase order to Duke University Office of Research Administration Division. Under this contract, Duke University will provide analysis of hemoglobin adducts of polycyclic aromatic hydrocarbons to the National Institutes of Health located in Bethesda, Maryland. Work will be conducted over a one year period from December...
This $229,949.71 federal contract award to Duke University was issued by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract, titled "BABY HUG FOLLOW-UP STUDY II", is a definitive contract with a cost-no-fee pricing type. The award has no set-aside designation and was issued on January 5, 2012 with an ultimate completion date of April 30, 2018. As the prime contractor, Duke University's Office of Research...
The National Institutes of Health (NIH) National Heart, Lung, and Blood Institute awarded a $11,936 firm fixed price purchase order to Duke University Office of Research Administration Division. The contract supports tuition fees for a researcher in the NIH-Duke Master's Program to continue taking courses. The program is a collaboration between NIH and Duke University to provide specialized training. Funding is provided by the Department of Health and Human Services NIH NHLBI. Performance will...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. government, has awarded a $11,816.00 firm fixed price purchase order to Duke University. The award will support Dr. Kam Ho's tuition fees for continuing courses in the NIH-Duke Master's program in which he is currently enrolled. The award has no set-aside designation. This purchase order award is part of Duke University's extensive portfolio of federal contract and grant awards, through which the...
This federal contract award is for $13,000 and was issued by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Esaote North America Inc., a foreign-owned, for-profit medical technology company, to provide structural heart medical imaging software to support the NHLBI Lederman Laboratory's staffing, workflow, and research priorities. The contract does not have a set-aside designation,...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $257,995.00, is for the Lung Tissue Research Consortium (LTRC) Tissue Repository task order 04, covering the period from January 1, 2019, to December 31, 2019. The prime contractor is National Jewish Health, a renowned non-profit hospital and research center in Denver, Colorado, that specializes in...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Duke University on September 25, 2023. The contract, valued at $220,108.00, is for the "Conduct of In Vitro Cardiovascular Toxicity Assays for the Division of Translational Toxicology" and has a completion date of December 31, 2024. The contract does not have a set-aside designation. Duke University's Office of Research Administration...
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $63,034 purchase order to Medviso AB. Under the contract, Medviso will provide CMR Analysis Packages site software to support research at the National Heart Lung and Blood Institute and Washington Hospital Center. The firm-fixed price contract runs from January 2021 through February 2022 and will be performed in Sweden. No set aside provisions or subcontractors were...
This is a $48,051,765.59 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) to provide biomedical research and related services. The contract has no set-aside designation and was awarded on September 22, 1994 with a completion date of June 20, 2014. As the prime contractor, UCLA's Office of Research Administration is leveraging the university's...

This is a $1,567,077.83 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health, to Duke University. The contract is for "Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe MRI" research and development services. The contract has a period of performance through November 14, 2020 and was awarded on November 15, 2016. The contract type is Cost No Fee. There is no set-aside designation for this award. Duke University, a private non-profit research institution, is the prime contractor. The award is part of NHLBI's broader research program to advance the understanding and treatment of cardiovascular and pulmonary diseases.

Generated 12/13/24, 9:38 AM